Akorn Inc. (AKRX) Drops 7.32% on January 15

Equities Staff |

Akorn Inc. (AKRX) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 7.32% to $28.10, a loss of $-2.22 per share. Starting at an opening price of $29.15 a share, the stock traded between $27.27 and $30.36 over the course of the trading day. Volume was 2.84 million shares over 18,903 trades, against an average daily volume of 1.61 million shares and a total float of 114.43 million.

The losses send Akorn Inc. down to a market cap of $3.22 billion. In the last year, Akorn Inc. has traded between $57.10 and $19.08, and its 50-day SMA is currently $33.58 and 200-day SMA is $39.36.

The stock has a P/E Ratio of 97.8.

Akorn Inc manufactures and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectable pharmaceuticals.

Akorn Inc. is based out of Lake forest, IL and has some 1,881 employees. Its CEO is Rajat Rai.

For a complete fundamental analysis analysis of Akorn Inc., check out Equities.com’s Stock Valuation Analysis report for AKRX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

H-Source Holdings Ltd.

H-Source Holdings Inc. is a technology company operating within the healthcare industry through its subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and…

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…